Free Medication Pop Quiz Part 3
This brief quiz written by Coach Beverly is designed to assess your knowledge about diabetes medications and recent care guidelines.

We have lots of FREE Resources and an Online University to help you keep current with the changing diabetes landscape. Interested in becoming a Diabetes Educator? Click here to get started: https://diabetesed.net/start-your-journey/

Email address *
The 2018 ADA Standards of Care include updates to the Pharmacologic Algorithm to manage hyperglycemia for individuals with type 2 diabetes. Which of the following accurately reflects updates to the algorithm?
0 points
The 2018 ADA Standards of Care include updates to the Cardiovascular Disease and risk management section. Which of the following accurately reflects updates to this section?
0 points
Semaglutide (Ozempic) is a newly approved GLP-1 Receptor Agonist with a few unique features. Which of the following statements is true about Semaglutide (Ozempic).
0 points
A new biosimilar insulin, lispro (Admelog) is now FDA Approved. Which of the following statement is true about biosimilar insulins.
0 points
Ertugliflozin (Steglatro) is a newly approved SGLT-2 Inhibitor. Teaching points for patients include which of the following?
0 points
A copy of your responses will be emailed to the address you provided.
Submit
reCAPTCHA
This form was created inside of Diabetes Educational Services. Report Abuse - Terms of Service